BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 17326474)

  • 1. [From gene to disease; cutaneous leiomyomatosis].
    Badeloe S; van Geel M; van Steensel MA; Steijlen PM; Poblete-Gutiérrez P; Frank JA
    Ned Tijdschr Geneeskd; 2007 Feb; 151(5):300-4. PubMed ID: 17326474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
    Alam NA; Olpin S; Leigh IM
    Br J Dermatol; 2005 Jul; 153(1):11-7. PubMed ID: 16029320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.
    Badeloe S; Frank J
    Eur J Dermatol; 2009; 19(6):545-51. PubMed ID: 19939761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed's syndrome).
    Rongioletti F; Fausti V; Ferrando B; Parodi A; Mandich P; Pasini B
    Dermatology; 2010; 221(4):378-80. PubMed ID: 21051878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
    Plevová P; Hladíková A; Tesařová M
    Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
    Smit DL; Mensenkamp AR; Badeloe S; Breuning MH; Simon ME; van Spaendonck KY; Aalfs CM; Post JG; Shanley S; Krapels IP; Hoefsloot LH; van Moorselaar RJ; Starink TM; Bayley JP; Frank J; van Steensel MA; Menko FH
    Clin Genet; 2011 Jan; 79(1):49-59. PubMed ID: 20618355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
    Ylisaukko-oja SK; Cybulski C; Lehtonen R; Kiuru M; Matyjasik J; Szymañska A; Szymañska-Pasternak J; Dyrskjot L; Butzow R; Orntoft TF; Launonen V; Lubiñski J; Aaltonen LA
    Eur J Hum Genet; 2006 Jul; 14(7):880-3. PubMed ID: 16639410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening.
    Tolvanen J; Uimari O; Ryynänen M; Aaltonen LA; Vahteristo P
    Hum Reprod; 2012 Jun; 27(6):1865-9. PubMed ID: 22473397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
    Varol A; Stapleton K; Roscioli T
    Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer.
    Alam NA; Olpin S; Rowan A; Kelsell D; Leigh IM; Tomlinson IP; Weaver T
    J Mol Diagn; 2005 Oct; 7(4):437-43. PubMed ID: 16237213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency.
    Alam NA; Rowan AJ; Wortham NC; Pollard PJ; Mitchell M; Tyrer JP; Barclay E; Calonje E; Manek S; Adams SJ; Bowers PW; Burrows NP; Charles-Holmes R; Cook LJ; Daly BM; Ford GP; Fuller LC; Hadfield-Jones SE; Hardwick N; Highet AS; Keefe M; MacDonald-Hull SP; Potts ED; Crone M; Wilkinson S; Camacho-Martinez F; Jablonska S; Ratnavel R; MacDonald A; Mann RJ; Grice K; Guillet G; Lewis-Jones MS; McGrath H; Seukeran DC; Morrison PJ; Fleming S; Rahman S; Kelsell D; Leigh I; Olpin S; Tomlinson IP
    Hum Mol Genet; 2003 Jun; 12(11):1241-52. PubMed ID: 12761039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer.
    Chan I; Wong T; Martinez-Mir A; Christiano AM; McGrath JA
    Clin Exp Dermatol; 2005 Jan; 30(1):75-8. PubMed ID: 15663510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
    Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ
    Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.
    Kiuru M; Lehtonen R; Arola J; Salovaara R; Järvinen H; Aittomäki K; Sjöberg J; Visakorpi T; Knuutila S; Isola J; Delahunt B; Herva R; Launonen V; Karhu A; Aaltonen LA
    Cancer Res; 2002 Aug; 62(16):4554-7. PubMed ID: 12183404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel FH mutation in a patient with cutaneous leiomyomatosis associated with cutis verticis gyrata, eruptive collagenoma and Charcot-Marie-Tooth disease.
    Marque M; Gardie B; Bressac de Paillerets B; Rustin P; Guillot B; Richard S; Bessis D
    Br J Dermatol; 2010 Dec; 163(6):1337-9. PubMed ID: 20560959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of somatic and germline mutations of Fumarate hydratase in uterine leiomyomas from young patients.
    Liu C; Dillon J; Beavis AL; Liu Y; Lombardo K; Fader AN; Hung CF; Wu TC; Vang R; Garcia JE; Xing D
    Histopathology; 2020 Feb; 76(3):354-365. PubMed ID: 31564060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
    Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology.
    Uimari O; Ahtikoski A; Kämpjärvi K; Butzow R; Järvelä IY; Ryynänen M; Aaltonen LA; Vahteristo P; Kuismin O
    Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2066-2075. PubMed ID: 34480341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer.
    Shuch B; Li S; Risch H; Bindra RS; McGillivray PD; Gerstein M
    Cancer; 2020 Aug; 126(16):3657-3666. PubMed ID: 32413184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of hereditary leiomyomatosis and renal cell cancer.
    Frey MK; Worley MJ; Heyman KP; Caputo TA
    Am J Obstet Gynecol; 2010 Jun; 202(6):e8-9. PubMed ID: 20510956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.